OtherJuly 21 at 10:20 AM

Eli Lily (LLY) says will vigorously defend in Novo Nordisk (NOVOB DC) lawsuit

StockNow breaking-news AI analysis

Novo Nordisk sued Eli Lilly today for deceptive advertising, claiming Lilly's GLP-1 ads misrepresent clinical data by comparing its highest doses to outdated, lower doses of Novo's medications.

2 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

U.S. Markets

Eli Lilly (LLY) Q2 2026 (USD): Adj. EPS 8.38 (exp. 6.01), Revenue 23bln (exp. 20.7bln)

LLY Geopolitics

Gulf official tells CNN “50:50” chance US and Iran could reach deal by Friday, CNN reports; Iranian delegation does not include IRGC, which would need to sign off on details of provisional agreement

U.S. Economy